Anna Wingate

1.4k total citations
9 papers, 337 citations indexed

About

Anna Wingate is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Anna Wingate has authored 9 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Anna Wingate's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Anna Wingate is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Anna Wingate collaborates with scholars based in United Kingdom, Italy and Spain. Anna Wingate's co-authors include Gerhardt Attard, C. R. M. Hay, Johann S. de Bono, Angela E. Taylor, Karolina Nowakowska, Iain J. McEwan, Carmel Pezaro, Jane Goodall, Suzanne Carreira and Wiebke Arlt and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Anna Wingate

9 papers receiving 334 citations

Peers

Countries citing papers authored by Anna Wingate

Since Specialization

Citations

This map shows the geographic impact of Anna Wingate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wingate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wingate more than expected).

Fields of papers citing papers by Anna Wingate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wingate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wingate. The network helps show where Anna Wingate may publish in the future.

Co-authorship network of co-authors of Anna Wingate

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wingate. A scholar is included among the top collaborators of Anna Wingate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wingate. Anna Wingate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	1656TiP The STAMPEDE2 niraparib-abiraterone acetate + prednisolone trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) with a deleterious alteration in a homologous recombination repair (HRR) gene starting androgen deprivation therapy (ADT) 2024 ·Annals of Oncology ·Sarah Howlett, (unknown), Louise Brown, Claire Amos, Peter Dutey‐Magni, (unknown), Laura E. O’Shea, Catherine A. Hogan, Anna Wingate, (unknown), Rosalind A. Eeles, Michael Hubank, Phillip Williams, William Cross, (unknown), Nigel Clarke, (unknown), Nicholas D. James, Emily Grist, (unknown)	1
2	The RECONCILE study protocol: Exploiting image-based risk stratification in early prostate cancer to discriminate progressors from non-progressors (RECONCILE) 2024 ·PLoS ONE ·(unknown), Gerhardt Attard, Shonit Punwani, Francesco Giganti, Alex Freeman, Aiman Haider, Anna Wingate, Norman Williams, (unknown), (unknown), Caroline M. Moore, Mark Emberton, Clément Orczyk	1
3	Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial 2021 ·Annals of Oncology ·Anuradha Jayaram, Anna Wingate, Daniel Wetterskog, Graham Wheeler, Cora N. Sternberg, Robert J. Jones, Alfredo Berruti, Florence Lefresne, Marjolein Lahaye, Shibu Thomas, Michael Gormley, (unknown), (unknown), (unknown), Axel S. Merseburger, Bertrand Tombal, Deborah Ricci, G. Attard	36
4	Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study 2021 ·European Journal of Cancer ·Vincenza Conteduca, Daniel Wetterskog, Elena Castro, Emanuela Scarpi, Nuria Romero-Laorden, Giorgia Gurioli, Anuradha Jayaram, Cristian Lolli, Giuseppe Schepisi, Anna Wingate, Chiara Casadei, Rebeca Lozano, Nicole Brighi, Isabel M. Aragón, Mercedes Marín‐Aguilera, Enrique González‐Billalabeitia, Begoña Mellado, David Olmos, Gerhardt Attard, Ugo De Giorgi	4
5	Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 2020 ·British Journal of Cancer ·Vincenza Conteduca, Daniel Wetterskog, Emanuela Scarpi, Alessandro Romanel, Giorgia Gurioli, Anuradha Jayaram, Cristian Lolli, Delila Gasi Tandefelt, Giuseppe Schepisi, Chiara Casadei, Anna Wingate, Federica Matteucci, Giovanni Paganelli, Enrique González‐Billalabeitia, Francesca Demichelis, Ugo De Giorgi, Gerhardt Attard	27
6	Genome-wide plasma DNA methylation features of metastatic prostate cancer 2020 ·Journal of Clinical Investigation ·Anjui Wu, Paolo Cremaschi, Daniel Wetterskog, Vincenza Conteduca, Gian Marco Franceschini, Dimitrios Kleftogiannis, Anuradha Jayaram, Shahneen Sandhu, Stephen Q. Wong, Matteo Benelli, Samanta Salvi, Giorgia Gurioli, Andrew Feber, Mariana Buongermino Pereira, Anna Wingate, Enrique González‐Billalabeitia, Ugo De Giorgi, Francesca Demichelis, Stefano Lise, Gerhardt Attard	64
7	Plasma androgen receptor (pAR) status and activity of taxanes in metastatic castration resistant prostate cancer (mCRPC). 2018 ·Journal of Clinical Oncology ·Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, Daniel Wetterskog, Samanta Salvi, Giorgia Gurioli, Emanuela Scarpi, Elena Castro, Mercedes Marín‐Aguilera, Cristian Lolli, Giuseppe Schepisi, Anna Wingate, Ana Medina, Giuseppe Fornarini, Umberto Basso, Begoña Mellado, Enrique González‐Billalabeitia, David Olmos, Gerhardt Attard, Ugo De Giorgi	2
8	Association of androgen receptor (AR) status in plasma DNA with outcome on enzalutamide (enza) or abiraterone (abi) for castration resistant prostate cancer (CRPC). 2017 ·Journal of Clinical Oncology ·Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani, Anuradha Jayaram, Samanta Salvi, Alessandro Romanel, Cristian Lolli, Valentina Casadio, Giorgia Gurioli, Dino Amadori, Delila Gasi Tandefelt, Anna Wingate, David P. Dearnaley, Francesca Demichelis, Ugo De Giorgi, Enrique González‐Billalabeitia, Gerhardt Attard	1
9	Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100 2012 ·Cancer Research ·(unknown), (unknown), C. R. M. Hay, Angela E. Taylor, Anna Wingate, Karolina Nowakowska, Carmel Pezaro, Suzanne Carreira, Jane Goodall, Wiebke Arlt, Iain J. McEwan, Johann S. de Bono, Gerhardt Attard	201

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact